Currently out of the existing stock ratings of George Sellers, 33 are a BUY (78.57%), 9 are a HOLD (21.43%).

George Sellers

Work Performance Price Targets & Ratings Chart

Analyst George Sellers, carries an average stock price target met ratio of 47.5% that have a potential upside of 13.73% achieved within 166 days. Previously, George Sellers worked at STEPHENS.

George Sellers’s has documented 83 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ESTA, Establishment Labs Holdings at 25-Feb-2026.

Wall Street Analyst George Sellers

Analyst best performing recommendations are on TMCI (TREACE MEDICAL CONCEPTS).
The best stock recommendation documented was for TMCI (TREACE MEDICAL CONCEPTS) at 4/10/2023. The price target of $26 was fulfilled within 2 days with a profit of $1.41 (5.14%) receiving and performance score of 25.72.

Average potential price target upside

ANIK Anika Therapeutics ESTA Establishment Labs Holdings TFX Teleflex TMDX TransMedics Group VCEL Vericel Corp Ord APYX Apyx Medical FNA Paragon 28 GKOS Glaukos Corp STAA STAAR Surgical Company TMCI Treace Medical Concepts

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 31-Jul-2025

$21

$-0.42 (-1.96%)

$16

2 months 26 days ago
(30-Jul-2026)

2/2 (100%)

$2.93 (16.21%)

134

Buy Since 03-Nov-2023

$17

$1.9 (12.58%)

$16

7 months 29 days ago
(27-Feb-2026)

14/22 (63.64%)

$2.64 (18.38%)

129

Hold Since 14-Oct-2022

$24

$8.9 (58.94%)

$23

2 years 4 months 27 days ago
(29-May-2024)

5/5 (100%)

$-1.64 (-6.40%)

129

Buy Since 09-Aug-2023

$32

$10.58 (49.39%)

3 years 2 months 17 days ago
(09-Aug-2023)

1/2 (50%)

$11.99 (59.92%)

73

Buy Since 15-Nov-2021

$35

$13.58 (63.40%)

$55

4 years 7 months 17 days ago
(09-Mar-2022)

0/2 (0%)

$8.78 (33.49%)

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?